The UK government is providing funding to bring a software tool used to monitor patients during surgery to market “as soon as possible”, says its developer.
An app combining physical therapy, relaxation exercises and medical education developed by Kaia Health has been shown to improve physical and mental symptoms in people with chr
US biotech AI Therapeutics has begun a phase 2 trial of its LAM-002A, an antiviral drug that has shown promise against the SARS-CoV-2 coronavirus in the lab.
A large-scale shift towards online GP appointments could reduce no shows, save businesses up to £1.5 billion in lost employee work time, and free up considerable capacity, says
Biocon has announced a deal with digital therapy specialist Voluntis, aiming to create personalised care for people with type 2 diabetes taking biosimilar insulins.
A smartphone app developed by medical software specialist Allm is being trialled in Japan to see if it can help patients with milder coronavirus symptoms recuperate at home, wi